These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9484644)
1. Special stains, the old and the new: the impact of immunocytochemistry in effusion cytology. Bedrossian CW Diagn Cytopathol; 1998 Feb; 18(2):141-9. PubMed ID: 9484644 [No Abstract] [Full Text] [Related]
2. Ancillary studies in pleural, pericardial, and peritoneal effusion cytology. Sundling KE; Cibas ES Cancer Cytopathol; 2018 Aug; 126 Suppl 8():590-598. PubMed ID: 30156768 [TBL] [Abstract][Full Text] [Related]
3. [Evaluation of immunohistochemistry staining and cytologic diagnosis by using cell block sections prepared with effusion fluid cytology specimens]. Mao YY; Yang M; Liu DG; Lin MH; Zhang LQ; Chen ZQ Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):547-50. PubMed ID: 20021967 [TBL] [Abstract][Full Text] [Related]
4. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers. Davidson B; Risberg B; Kristensen G; Kvalheim G; Emilsen E; Bjåmer A; Berner A Virchows Arch; 1999 Jul; 435(1):43-9. PubMed ID: 10431845 [TBL] [Abstract][Full Text] [Related]
5. Morphologic and immunocytochemical performances of effusion cell blocks prepared using 3 different methods. Jing X; Li QK; Bedrossian U; Michael CW Am J Clin Pathol; 2013 Feb; 139(2):177-82. PubMed ID: 23355202 [TBL] [Abstract][Full Text] [Related]
6. Comparison of immunocytochemical sensitivity between formalin-fixed and alcohol-fixed specimens reveals the diagnostic value of alcohol-fixed cytocentrifuged preparations in malignant effusion cytology. Ikeda K; Tate G; Suzuki T; Mitsuya T Am J Clin Pathol; 2011 Dec; 136(6):934-42. PubMed ID: 22095380 [TBL] [Abstract][Full Text] [Related]
7. The significance of detecting glucose transporter 1 and calretinin in serous effusions to differentiate between carcinoma cells and reactive mesothelial cells. Lv M; Cha N; Zou YF; Leng JH; Hao YY; Wang S Diagn Cytopathol; 2021 Jul; 49(7):811-816. PubMed ID: 33818924 [TBL] [Abstract][Full Text] [Related]
8. Utility of Sry-Related HMG-Box Gene 10 (SOX10) as a marker of melanoma in effusion cytology. Dermawan JKT; Underwood D; Policarpio-Nicolas ML Diagn Cytopathol; 2019 Jul; 47(7):653-658. PubMed ID: 30794352 [TBL] [Abstract][Full Text] [Related]
9. Cytomorphological profile of neoplastic effusions: an audit of 10 years with emphasis on uncommonly encountered malignancies. Gupta S; Sodhani P; Jain S J Cancer Res Ther; 2012; 8(4):602-9. PubMed ID: 23361282 [TBL] [Abstract][Full Text] [Related]
10. Early diagnosis of mesothelioma in serous effusions using AgNOR analysis. Pomjanski N; Motherby H; Buckstegge B; Knops K; Rohn BL; Böcking A Anal Quant Cytol Histol; 2001 Apr; 23(2):151-60. PubMed ID: 11332082 [TBL] [Abstract][Full Text] [Related]
11. [Differential diagnostic value of B72.3, Ber-EP4 and calretinin in serous effusions]. Li XJ; Pan QJ; Shen GH; Liu XY; Sun YT Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):438-41. PubMed ID: 16188134 [TBL] [Abstract][Full Text] [Related]
12. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens. Shield PW; Papadimos DJ; Walsh MD Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220 [TBL] [Abstract][Full Text] [Related]
13. Detection of hyperdiploid malignant cells in body cavity effusions by fluoresence in situ hybridization on ThinPrep slides. Florentine BD; Sanchez B; Raza A; Frankel K; Martin SE; Kovacs B; Felix JC Cancer; 1997 Oct; 81(5):299-308. PubMed ID: 9349518 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of E-cadherin for malignanteffusions: a systematic review and meta-analysis. Chen F; Dai L; An J; Zeng N; Chen L; Shen Y Postgrad Med J; 2020 Sep; 96(1139):530-536. PubMed ID: 31818872 [TBL] [Abstract][Full Text] [Related]
15. Morphologic analysis of serous effusion cells by scanning electron microscopy. Cappellari A; Furlan C; Cardellini P; Bagarella M; Corradi G Tumori; 1992 Feb; 78(1):10-2. PubMed ID: 1609452 [TBL] [Abstract][Full Text] [Related]
16. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center. Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444 [TBL] [Abstract][Full Text] [Related]
17. Application of multicolour flow cytometry in the detection of metastatic carcinoma in serous effusions: Special emphasis in atypical cytology. Sahu S; Gupta P; Susheilia S; Gautam U; Dey P Cytopathology; 2021 Mar; 32(2):169-179. PubMed ID: 33040400 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations. Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T Diagn Cytopathol; 2011 Jun; 39(6):395-401. PubMed ID: 21574259 [TBL] [Abstract][Full Text] [Related]
19. Analysis of diagnostic value of cytological smear method versus cell block method in body fluid cytology: study of 150 cases. Bhanvadia VM; Santwani PM; Vachhani JH Ethiop J Health Sci; 2014 Apr; 24(2):125-31. PubMed ID: 24795513 [TBL] [Abstract][Full Text] [Related]
20. Telomerase activity analyzed with TRAP in situ provides additional information in effusions remaining equivocal after immunocytochemistry and hyaluronan analysis. Adell E; Dejmek A Diagn Cytopathol; 2014 Dec; 42(12):1051-7. PubMed ID: 24692425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]